Nigrostriatal dopamine transporter availability in early Parkinson's disease-Reference-Cited by-同舟云学术

Nigrostriatal dopamine transporter availability in early Parkinson's disease

Published:2018-02-13 Issue:4 Volume:33 Page:592-599
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord.

Author:

Fazio Patrik¹^ORCID,Svenningsson Per²,Cselényi Zsolt¹³,Halldin Christer¹,Farde Lars¹³,Varrone Andrea¹

Affiliation:

1. Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet and Stockholm County Council; Stockholm Sweden

2. Department of Clinical Neuroscience, Centre for Molecular Medicine, Karolinska Institutet; Stockholm Sweden

3. PET Science Centre, Precision Medicine and Genomics, Innovative Medicine & Early Development (IMED) Biotech Unit, AstraZeneca, Karolinska Institutet; Sweden

Funder

Swedish Foundation for Strategic Research

AstraZeneca Translational Science Centre at Karolinska Institutet

Swedish Parkinson's Disease Foundation

Swedish Science Council

Swedish Parkinson Foundation

AstraZeneca Translational Science Centre at KI

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Reference36 articles.

1. The pathomechanisms underlying Parkinson's disease;Jellinger;Expert Rev Neurother,2014

2. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease;Gibb;J Neurol Neurosurg Psychiatry,1988

3. Clinical progression in Parkinson's disease and the neurobiology of Axons;Cheng;Ann Neurol,2010

4. Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro;Burre;Science,2010

5. Disease duration and the integrity of the nigrostriatal system in Parkinson's disease;Kordower;Brain,2013

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical assessment and striatal dopaminergic activity in healthy controls and patients with Parkinson’s disease: a Bayesian approach;Annals of Nuclear Medicine;2024-08-27

2. GDNF improves the cognitive ability of PD mice by promoting glycosylation and membrane distribution of DAT;Scientific Reports;2024-08-01

3. (+)-Borneol Protects Dopaminergic Neuronal Loss in Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Induced Parkinson’s Disease Mice: A Study of Dopamine Level using In Vivo Brain Microdialysis;ACS Chemical Neuroscience;2024-05-15

4. Misfolded protein deposits in Parkinson’s disease and Parkinson’s disease-related cognitive impairment, a [11C]PBB3 study;npj Parkinson's Disease;2024-05-03

5. GDNF improves the cognitive ability of PD mice by promoting glycosylation and membrane distribution of DAT;2024-03-29